Soligenix, Inc. (SNGX) Financial Statements (2024 and earlier)

Company Profile

Business Address 29 EMMONS DRIVE
PRINCETON, NJ 08540
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments  26,04418,6775,4218,9847,809
Cash and cash equivalents  26,04418,6775,4218,9847,809
Receivables2192432041,0191,2021,343
Prepaid expense274283225610157263
Deferred costs    39  
Other undisclosed current assets13,360 361405  
Total current assets:13,85326,57019,4677,49310,3439,416
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization   6 
Operating lease, right-of-use asset341   
Property, plant and equipment182224362037
Intangible assets, net (including goodwill)    204774
Intangible assets, net (excluding goodwill)    204774
Capitalized contract cost, net24121   
Deposits noncurrent assets232323232323
Asset, held-in-trust  106228125  
Deferred costs2020    
Other noncurrent assets  82339  
Other undisclosed noncurrent assets   1213960 
Total noncurrent assets:427300424282149134
TOTAL ASSETS:14,28026,87019,8917,77510,4929,550
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,1746,1855,6436,1914,2123,230
Employee-related liabilities303875298295333
Accounts payable3,8662,9262,1302,7352,1261,754
Accrued liabilities2,3082,9572,6383,1571,7911,143
Debt9,898 331   
Other undisclosed current liabilities446106106121  
Total current liabilities:16,5176,2916,0816,3124,2123,230
Noncurrent Liabilities
Long-term debt and lease obligation   93   
Long-term debt, excluding current maturities   93   
Liabilities, other than long-term debt234     
Operating lease, liability234   
Other undisclosed noncurrent liabilities 9,8569,9766  
Total noncurrent liabilities:2349,85610,0696  
Total liabilities:16,75116,14716,1496,3184,2123,230
Temporary equity, carrying amount 0     
Equity
Equity, attributable to parent(2,471)10,7233,7421,4576,2806,320
Common stock3433122189
Additional paid in capital217,065216,403196,950177,006172,436163,581
Accumulated other comprehensive income (loss)2542(24)(45)(4) 
Accumulated deficit(219,563)(205,765)(193,214)(175,526)(166,170)(157,270)
Total equity:(2,471)10,7233,7421,4576,2806,320
TOTAL LIABILITIES AND EQUITY:14,28026,87019,8917,77510,4929,550

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues9498242,3594,6305,2415,432
Revenue, net5,432
Cost of revenue(551)(729)(1,821)(3,567)(4,598)(4,310)
Gross profit:398965381,0636441,122
Operating expenses(14,637)(13,237)(19,125)(11,604)(9,703)(8,716)
Operating loss:(14,239)(13,141)(18,587)(10,541)(9,059)(7,594)
Nonoperating income (expense)(714)(314)(23)15715930
Investment income, nonoperating    14915930
Gain (loss), foreign currency transaction, before tax(31)(39)(23)8  
Other nonoperating income (expense)6(275)    
Interest and debt expense (0)(62)(7)  
Other undisclosed income from continuing operations before equity method investments, income taxes   146425  
Loss from continuing operations before equity method investments, income taxes:(14,953)(13,455)(18,525)(9,966)(8,900)(7,564)
Other undisclosed income from continuing operations before income taxes 40    
Loss from continuing operations before income taxes:(14,953)(13,416)(18,525)(9,966)(8,900)(7,564)
Income tax benefit1,155865837611 417
Loss from continuing operations:(13,798)(12,551)(17,689)(9,356)(8,900)(7,147)
Loss before gain (loss) on sale of properties:(12,551)(17,689)(9,356)(8,900)(7,147)
Net loss available to common stockholders, diluted:(13,798)(12,551)(17,689)(9,356)(8,900)(7,147)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(13,798)(12,551)(17,689)(9,356)(8,900)(7,147)
Comprehensive loss:(13,798)(12,551)(17,689)(9,356)(8,900)(7,147)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(17)6621(41)(4) 
Comprehensive loss, net of tax, attributable to parent:(13,816)(12,485)(17,668)(9,397)(8,904)(7,147)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: